• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

核医学中的治疗与诊断探针及纳米治疗与诊断探针

Theranostic and nanotheranostic probes in nuclear medicine.

机构信息

Department of Nuclear Medicine, Uniklinik RWTH Aachen University, Germany; Leibniz Institute for Interactive Materials - DWI, RWTH Aachen University, Germany.

Department of Nuclear Medicine, Uniklinik RWTH Aachen University, Germany; Institute of Inorganic Chemistry, RWTH Aachen University, Germany.

出版信息

Methods. 2017 Nov 1;130:14-22. doi: 10.1016/j.ymeth.2017.07.004. Epub 2017 Jul 8.

DOI:10.1016/j.ymeth.2017.07.004
PMID:28698069
Abstract

In nuclear medicine, a theranostic probe describes a substance that combines diagnostic and therapeutic capabilities by radiolabeling it with different radionuclides. Next to a brief description of the different emitters (α, β, β, γ) used for imaging and/or therapy, the aim of this review is to summarize the most commonly used theranostic probes in nuclear medicine. Another goal is to give an idea which chemical requirements need to be fulfilled for radiolabeling with either therapeutic and/or diagnostic relevant nuclides. Furthermore, a perspective is given into the field of nanotheranostics which is gaining more and more attention in nuclear medicine. The combination has been called radionanomedicine and is a very proliferative field with an enormous potential.

摘要

在核医学中,治疗诊断探针是指通过用不同的放射性核素来标记该物质,从而将诊断和治疗功能结合在一起的一种物质。本文除了简要描述用于成像和/或治疗的不同发射体(α、β、β+、γ)外,还旨在总结核医学中最常用的治疗诊断探针。另一个目标是给出用治疗和/或诊断相关核素进行放射性标记所需满足的化学要求的想法。此外,本文还介绍了纳米治疗诊断学领域,该领域在核医学中越来越受到关注。这种结合被称为放射纳米医学,是一个具有巨大潜力的快速发展领域。

相似文献

1
Theranostic and nanotheranostic probes in nuclear medicine.核医学中的治疗与诊断探针及纳米治疗与诊断探针
Methods. 2017 Nov 1;130:14-22. doi: 10.1016/j.ymeth.2017.07.004. Epub 2017 Jul 8.
2
Scandium and terbium radionuclides for radiotheranostics: current state of development towards clinical application.用于放射治疗诊断的钪和铽放射性核素:临床应用的当前发展状况
Br J Radiol. 2018 Nov;91(1091):20180074. doi: 10.1259/bjr.20180074. Epub 2018 Jun 15.
3
Nuclear medicine for all the world--from molecular imaging to molecular medicine.面向全球的核医学——从分子影像到分子医学。
J Korean Med Sci. 2007 Aug;22(4):595-7. doi: 10.3346/jkms.2007.22.4.595.
4
Toward Independent Nuclear Medicine, Molecular Imaging, and Theranostic Programs.迈向独立的核医学、分子影像和诊疗一体化项目。
J Nucl Med. 2019 Aug;60(8):1037. doi: 10.2967/jnumed.119.233627.
5
Progress in the Development of Nanotheranostic Systems.纳米诊疗系统的发展进展
Theranostics. 2016 May 19;6(7):915-7. doi: 10.7150/thno.16153. eCollection 2016.
6
[Oncological theranostics in nuclear medicine].[核医学中的肿瘤诊疗一体化]
Radiologie (Heidelb). 2022 Oct;62(10):875-884. doi: 10.1007/s00117-022-01072-w.
7
Editorial: symposium on nuclear imaging in dementia and depression.社论:痴呆与抑郁症的核医学成像研讨会
Nucl Med Commun. 2005 Mar;26(3):181-2. doi: 10.1097/00006231-200503000-00001.
8
Towards Clinical Development of Scandium Radioisotope Complexes for Use in Nuclear Medicine: Encouraging Prospects with the Chelator 1,4,7,10-Tetraazacyclododecane-1,4,7,10-tetraacetic Acid (DOTA) and Its Analogues.走向用于核医学的钪放射性同位素配合物的临床开发:用螯合剂 1,4,7,10-四氮杂环十二烷-1,4,7,10-四乙酸(DOTA)及其类似物带来的可喜前景。
Int J Mol Sci. 2024 May 29;25(11):5954. doi: 10.3390/ijms25115954.
9
Current and Future Theranostic Applications of the Lipid-Calcium-Phosphate Nanoparticle Platform.脂质-钙-磷酸纳米颗粒平台的当前及未来诊疗应用
Theranostics. 2016 Apr 27;6(7):918-29. doi: 10.7150/thno.14689. eCollection 2016.
10
Theranostic Outcomes in Clinical Practice of Oncology: What, So What, Now What? What's More.肿瘤临床实践中的诊疗一体化结果:是什么、那又如何、现在该怎么办?此外。
Cancer Biother Radiopharm. 2019 Apr;34(3):135-140. doi: 10.1089/cbr.2019.29006.jht.

引用本文的文献

1
Nanoradiopharmaceuticals: Design Principles, Radiolabeling Strategies, and Biomedicine Applications.纳米放射性药物:设计原理、放射性标记策略及生物医学应用。
Pharmaceutics. 2025 Jul 14;17(7):912. doi: 10.3390/pharmaceutics17070912.
2
Charting the coordinative landscape of the F-Sc/Sc/Lu triad with the tri-aza-cyclononane (tacn) scaffold.绘制具有三氮杂环壬烷(tacn)支架的F-Sc/Sc/Lu三元组的配位格局。
Chem Sci. 2024 Oct 3;15(43):17927-36. doi: 10.1039/d4sc04735d.
3
EANM guidance document: dosimetry for first-in-human studies and early phase clinical trials.
EANM 指导文件:用于首次人体研究和早期临床试验的剂量学。
Eur J Nucl Med Mol Imaging. 2024 Apr;51(5):1268-1286. doi: 10.1007/s00259-024-06640-x. Epub 2024 Feb 17.
4
Synthesis, radiolabeling, and evaluation of 68Ga-labeled aminoquinoxaline derivative as a potent PFKFB3-targeted PET tracer.68Ga标记的氨基喹喔啉衍生物作为一种有效的靶向PFKFB3的PET示踪剂的合成、放射性标记及评估
Front Chem. 2023 Mar 22;11:1158503. doi: 10.3389/fchem.2023.1158503. eCollection 2023.
5
Expanding Theranostic Radiopharmaceuticals for Tumor Diagnosis and Therapy.用于肿瘤诊断与治疗的放射性核素诊疗药物的拓展
Pharmaceuticals (Basel). 2021 Dec 22;15(1):13. doi: 10.3390/ph15010013.
6
Obstacles and Recommendations for Clinical Translation of Nanoparticle System-Based Targeted Alpha-Particle Therapy.基于纳米颗粒系统的靶向α粒子治疗临床转化的障碍与建议
Materials (Basel). 2021 Aug 24;14(17):4784. doi: 10.3390/ma14174784.
7
A perspective on the radiopharmaceutical requirements for imaging and therapy of glioblastoma.探讨脑胶质瘤影像诊断与治疗用放射性药物需求的观点。
Theranostics. 2021 Jul 6;11(16):7911-7947. doi: 10.7150/thno.56639. eCollection 2021.
8
Theranostic Terbium Radioisotopes: Challenges in Production for Clinical Application.治疗诊断用铽放射性同位素:临床应用生产中的挑战
Front Med (Lausanne). 2021 May 31;8:675014. doi: 10.3389/fmed.2021.675014. eCollection 2021.
9
Radiolabeling of Theranostic Nanosystems.治疗诊断纳米系统的放射性标记
Adv Exp Med Biol. 2021;1295:49-76. doi: 10.1007/978-3-030-58174-9_3.
10
The utility of PET/CT in large vessel vasculitis.PET/CT 在大血管血管炎中的应用。
Sci Rep. 2020 Oct 19;10(1):17709. doi: 10.1038/s41598-020-73818-2.